Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Urolithin A is a secondary metabolite of ellagic acid, a polyphenolic antioxidant, that has antiproliferative, anti-inflammatory, and anti-oxidant properties.
説明 | Urolithin A is a secondary metabolite of ellagic acid, a polyphenolic antioxidant, that has antiproliferative, anti-inflammatory, and anti-oxidant properties. |
In vitro | Urolithin A decreases proliferation in ECC-1, Ishikawa, and HEC-1A human endometrial cancer cell lines at a concentration of 1 μM, arrests the cell cycle at the G2/M transition, and modulates estrogen receptor-regulated gene expression[1]. |
分子量 | 228.2 |
分子式 | C13H8O4 |
CAS No. | 1143-70-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (219.11 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Urolithin A 1143-70-0 Apoptosis Autophagy Cell Cycle/Checkpoint DNA Damage/DNA Repair Immunology/Inflammation Metabolism NF-Κb DNA/RNA Synthesis Endogenous Metabolite Reactive Oxygen Species Drug Metabolite Inhibitor inhibit inhibitor